Impact of telemedicine adoption on accessibility and time to treatment in patients with thoracic malignancies during the COVID-19 pandemic
Open Access
- 11 October 2021
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 21 (1) , 1-8
Abstract
Background: To ensure safe delivery of oncologic care during the COVID-19 pandemic, telemedicine has been rapidly adopted. However, little data exist on the impact of telemedicine on quality and accessibility of oncologic care. This study assessed whether conducting an office visit for thoracic oncology patients via telemedicine affected time to treatment initiation and accessibility. Methods: This was a retrospective cohort study of patients with thoracic malignancies seen by a multidisciplinary team during the first surge of COVID-19 cases in Philadelphia (March 1 to June 30, 2020). Patients with an index visit for a new phase of care, defined as a new diagnosis, local recurrence, or newly discovered metastatic disease, were included. Results: 240 distinct patients with thoracic malignancies were seen: 132 patients (55.0%) were seen initially in-person vs 108 (45.0%) via telemedicine. The majority of visits were for a diagnosis of a new thoracic cancer (87.5%). Among newly diagnosed patients referred to the thoracic oncology team, the median time from referral to initial visit was significantly shorter amongst the patients seen via telemedicine vs. in-person (median 5.0 vs. 6.5 days, p < 0.001). Patients received surgery (32.5%), radiation (24.2%), or systemic therapy (30.4%). Time from initial visit to treatment initiation by modality did not differ by telemedicine vs in-person: surgery (22 vs 16 days, p = 0.47), radiation (27.5 vs 27.5 days, p = 0.86, systemic therapy (15 vs 13 days, p = 0.45). Conclusions: Rapid adoption of telemedicine allowed timely delivery of oncologic care during the initial surge of the COVID19 pandemic by a thoracic oncology multi-disciplinary clinic.Keywords
This publication has 32 references indexed in Scilit:
- Typical Time to Treatment of Patients With Lung Cancer in a Multisite, US-Based StudyJournal of Oncology Practice, 2016
- Delivering kidney cancer care in rural Central and Southern Illinois: a telemedicine approachEuropean Journal of Cancer Care, 2014
- Telemedicine for rural cancer care in North Queensland: Bringing cancer care homeAustralian Journal of Rural Health, 2012
- Toward Patient-Centered Cancer Care: Patient Perceptions of Problematic Events, Impact, and ResponseJournal of Clinical Oncology, 2012
- Effect of Telecare Management on Pain and Depression in Patients With CancerJAMA, 2010
- Teleoncology: current and future applications for improving cancer care globallyThe Lancet Oncology, 2010
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational StudiesAnnals of Internal Medicine, 2007
- Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: A first step toward implementing a multidisciplinary, evidence-based guidelineLung Cancer, 2006
- Cancer diagnosis and telemedicine: a case study from CambodiaAnnals of Oncology, 2006
- BTS recommendations to respiratory physicians for organising the care of patients with lung cancerThorax, 1998